Analysis of SETD7 mRNA in 35 bone marrow aspirates from AML patients and in 8 from healthy patients showed SETD7 expression was high in the healthy group and low or weak levels in 18 out of the 35 (51.4%) bone marrow samples from AML patients [31]. This evidence concerns the gene SETD7 and acute myeloid leukemia.